| Credit Designation |
| The
Academy of Medicine of New Jersey designates this activity for a maximum of 1 hour in
category 1 credit towards the AMA Physician's Recognition Award. Each physician
should claim only those hours of credit that he/she actually spent in the educational
activity. |
| ACCREDITATION STATEMENT: |
| This activity has been planned and
implemented in accordance with the Essential Areas and Policies of the Accreditation
Council for Continuing Medical Education (ACCME) through the joint sponsorship of The
Academy of Medicine of New Jersey and the Distance Learning Network. The Academy of
Medicine of New Jersey is accredited by the ACCME to provide continuing medical education
for physicians and takes responsibility of the content, quality, and scientific integrity
of this CME activity. |
| DISCLOSURE STATEMENT: |
| It is the policy of AMNJ to ensure
balance, independence, objectivity, and scientific rigor in all its sponsored educational
programs. All faculty participating in programs sponsored by AMNJ are expected to
disclose to the program audience any relationship with a commercial entity that might pose
a potential, apparent, or real conflict of interest with regard to the content of their
presentation(s). |
Disclosure |
| Dr.
Paul will discuss Rapid HIV Diagnostic Testing, Anti Retroviral Agents,
Resistance Testing for HIV |
| Dr.
Bardeguez is a Consultant, on the Speaker's Bureau, conducts research for Glaxo-Wellcome
and conducts research for Roche. |
| Dr.
Librizzi has no relationship to disclose. |
| Dr.
Burr has no relationship to disclose. |
